Symbol="EQRX"
AssetType="Common Stock"
Name="EQRx Inc"
Description="EQRx, Inc., a pharmaceutical company, is engaged in the development of drugs primarily for the treatment of cancer and immuno-inflammatory diseases in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1843762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="C/O CORVEX MANAGEMENT LP, 667 MADISON AVENUE, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1077063000"
EBITDA="-367683008"
PERatio="None"
PEGRatio="None"
BookValue="2.733"
DividendPerShare="0"
DividendYield="0"
EPS="-0.57"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.151"
ReturnOnEquityTTM="-0.19"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="2.1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.998"
EVToRevenue="-"
EVToEBITDA="0.281"
Beta="0.626"
num_52WeekHigh="6.05"
num_52WeekLow="1.58"
num_50DayMovingAverage="1.876"
num_200DayMovingAverage="2.475"
SharesOutstanding="487359000"
DividendDate="None"
ExDividendDate="None"
symbol="EQRX"
open="2.23"
high="2.27"
low="2.20"
price="2.23"
volume="19251486.00"
latest_trading_day="2023-08-04"
previous_close="2.21"
change="0.02"
change_percent="0.9050%"
aroon_positive_momentum_days="28"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="3430246"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0073.jpeg"
image_negative_thumbnail_id_2="150"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0026.jpeg"
image_neutral_thumbnail_id_1="597"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_neutral_thumbnail_id_2="541"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_positive_thumbnail_id_1="948"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0110.jpeg"
image_positive_thumbnail_id_2="702"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
